Health

Roche forges antibiotics pact as it sees beyond COVID-19 threats to public health

13 days ago   |   By Fierce Biotech

Swiss major Roche, already ramping up tests for the COVID-19 pandemic, isn't taking its eye off of the infectious disease ball.
Read more ...

 

Research After COVID-19? Hold That Thought Says Infectious Diseases Expert

Research After COVID-19? Hold That Thought Says Infectious Diseases Expert

13 days ago   |   By Discovery's Edge

"When this ends ..."
"Research of the future will ..."
"After this experience ..."
These phrases are starting to show up in news stories, online conversations, and quotes from medical and research leaders. This pivot to the future is a reasonable twist, considering the enormity of the COVID-19 pandemic.
This pandemic may change the way we live and work. But, says
Gregory
Poland, M.D. , director of Mayo Clinic's Vaccine
Research Group , "Right now we still see people crowded in bars and restaurants, partying. Right now, we can't get people to stay home. In addition, we have to get...
Read more ...

 


Search by Tags

   Health      Antibiotics      Vaccine      Clinical      Vaccines      Research      Featured      Rotator      COVID-19      Gregory Poland      SARS-CoV-2  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Convalescent Plasma: A Therapy for COVID-19?

Convalescent Plasma: A Therapy for COVID-19?

To develop a treatment for patients with COVID-19, researchers around the world are steadfastly exploring numerous angles, including testing existing antiviral drugs and new... Read more ...

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

The financial markets may remain volatile but Keros Therapeutics managed to raise more money in its public market debut than it had initially planned. Late Tuesday the... Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The... Read more ...

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including... Read more ...

Creating Consistent Value in Biotech Without Diluting Stakeholders

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide... Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us... Read more ...

Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test

Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test

Millendo Therapeutics is considering a corporate reorganization after its lead drug, an investigational treatment for a rare genetic condition characterized by unrelenting... Read more ...

Menlo's Itching Drug Racks Up Two More Trial Failures, Program Ends

Menlo's Itching Drug Racks Up Two More Trial Failures, Program Ends

An itching drug that was a key part of the merger of Menlo Therapeutics and Foamix Pharmaceuticals has failed two late-stage studies, leading to a halt on further development... Read more ...

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel...

Premier Biomedical Realigns Business to Eliminate Convertible Debt, Cancel Reverse Split & Fund Covid-19 R&D

Jackson Center, PA, April 6, 2020 - Premier Biomedical, Inc. announced a multi-faceted agreement to eliminate the Convertible Notes as an obligation of Premier, cancel the... Read more ...

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

GlaxoSmithKline has agreed to invest $250 million in infectious disease specialist Vir Biotechnology to launch a COVID-19 R&D alliance that the companies say could advance two... Read more ...